Correlation Between Tcr2 Therapeutics and Revolution Medicines

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tcr2 Therapeutics and Revolution Medicines at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tcr2 Therapeutics and Revolution Medicines into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tcr2 Therapeutics and Revolution Medicines, you can compare the effects of market volatilities on Tcr2 Therapeutics and Revolution Medicines and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tcr2 Therapeutics with a short position of Revolution Medicines. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tcr2 Therapeutics and Revolution Medicines.

Diversification Opportunities for Tcr2 Therapeutics and Revolution Medicines

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Tcr2 and Revolution is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Tcr2 Therapeutics and Revolution Medicines in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Revolution Medicines and Tcr2 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tcr2 Therapeutics are associated (or correlated) with Revolution Medicines. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Revolution Medicines has no effect on the direction of Tcr2 Therapeutics i.e., Tcr2 Therapeutics and Revolution Medicines go up and down completely randomly.

Pair Corralation between Tcr2 Therapeutics and Revolution Medicines

If you would invest (100.00) in Tcr2 Therapeutics on December 29, 2024 and sell it today you would earn a total of  100.00  from holding Tcr2 Therapeutics or generate -100.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Tcr2 Therapeutics  vs.  Revolution Medicines

 Performance 
       Timeline  
Tcr2 Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Tcr2 Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Tcr2 Therapeutics is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.
Revolution Medicines 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Revolution Medicines has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's primary indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Tcr2 Therapeutics and Revolution Medicines Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tcr2 Therapeutics and Revolution Medicines

The main advantage of trading using opposite Tcr2 Therapeutics and Revolution Medicines positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tcr2 Therapeutics position performs unexpectedly, Revolution Medicines can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Revolution Medicines will offset losses from the drop in Revolution Medicines' long position.
The idea behind Tcr2 Therapeutics and Revolution Medicines pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Complementary Tools

Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Fundamental Analysis
View fundamental data based on most recent published financial statements